# Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy

> **NCT02137863** · PHASE4 · COMPLETED · sponsor: **TC Erciyes University** · enrollment: 60 (actual)

## Conditions studied

- Radiographic Contrast Agent Nephropathy

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** 0.9 % NaCl
- **DRUG:** 0.9 % NaCl

## Key facts

- **NCT ID:** NCT02137863
- **Lead sponsor:** TC Erciyes University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137863, "Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02137863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*